$LABT

$2.24▲ +12.6% YTD

8 SEC 13D/G filings tracked · Last updated Sep 21, 2026

Filing History

LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc.

CP $2.24▲ +12.6%Sep 21, 2026 · ThinkSabio Blog

$LABT - Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3…

News

LABT ▲ +5.3% - Lakewood-Amedex Biotherapeutics, Inc.

CP $1.97▲ +5.3%Sep 18, 2026 · ThinkSabio Blog

$LABT - Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatme…

News

LABT ▲ +1.1% - Lakewood-Amedex Biotherapeutics, Inc.

CP $1.90▲ +1.1%Sep 8, 2026 · ThinkSabio Blog

$LABT - Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference…

News

LABT ▲ +47.8% - Lakewood-Amedex Biotherapeutics, Inc.

CP $3.40▲ +47.8%Aug 31, 2026 · ThinkSabio Blog

$LABT vol pop AHs - off earlier patent talk…

News

LABT ▲ +47.8% - Lakewood-Amedex Biotherapeutics, Inc.

CP $3.40▲ +47.8%Aug 31, 2026 · ThinkSabio Blog

$LABT some vol…

News

LABT ▲ +47.8% - Lakewood-Amedex Biotherapeutics, Inc.

CP $3.40▲ +47.8%Aug 31, 2026 · ThinkSabio Blog

$LABT patent news…

SEC 13D/G

LABT - Lakewood-Amedex Biotherapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$2.15▼ -75.14%Aug 14, 2026 · ThinkSabio Blog

$LABT SEC 13D/G institutional ownership filing. Others sector. SEC Filing Update: #LABT Lakewood-Amedex Biotherapeutics, Inc. : $2.15 Sector: Others |…

SEC 13D/G

LABT - Lakewood-Amedex Biotherapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$2.35▼ -72.83%Aug 6, 2026 · ThinkSabio Blog

$LABT SEC 13D/G institutional ownership filing. Others sector. SEC Filing Update: #LABT Lakewood-Amedex Biotherapeutics, Inc. : $2.35 Sector: Others |…